Erythropoietin for neurologic protection and diabetic neuropathy.
Lipton
Stuart A
SA
Burnham Institute, and the University of California at San Diego, La Jolla, USA.
D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy; D003929:Diabetic Neuropathies / Q000188:drug therapy / Q000517:prevention & control*; D004921:Erythropoietin / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use*; D006400:Hematocrit; D006801:Humans; D009474:Neurons / Q000187:drug effects* / Q000502:physiology; D009619:Nociceptors / Q000187:drug effects; D011994:Recombinant Proteins; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism
D011994:Recombinant Proteins; D004921:Erythropoietin; D000254:Sodium-Potassium-Exchanging ATPase